• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

古洛糖醛酸能抑制铜(II)和淀粉样-β肽的配位,减少与阿尔茨海默病相关的铜相关活性氧的形成。

Guluronic acid can inhibit copper(II) and amyloid - β peptide coordination and reduce copper-related reactive oxygen species formation associated with Alzheimer's disease.

机构信息

State Key Laboratory of Biobased Materials and Green Papermaking, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong 250353, PR China.

State Key Laboratory of Biobased Materials and Green Papermaking, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong 250353, PR China.

出版信息

J Inorg Biochem. 2023 Aug;245:112252. doi: 10.1016/j.jinorgbio.2023.112252. Epub 2023 May 6.

DOI:10.1016/j.jinorgbio.2023.112252
PMID:37207465
Abstract

Copper-related reactive oxygen species (ROS) formation can lead to neuropathologic degradation associated with Alzheimer's disease (AD) according to amyloid cascade hypothesis. A complexing agent that can selectively chelate with copper ions and capture copper ions from the complex formed by copper ions and amyloid-β (Cu - Aβ complex) may be available in reducing ROS formation. Herein, we described applications of guluronic acid (GA), a natural oligosaccharide complexing agent obtained from enzymatic hydrolysis of brown algae, in reducing copper-related ROS formation. UV-vis absorption spectra demonstrated the coordination between GA and Cu(II). Ascorbic acid consumption and coumarin-3-carboxylic acid fluorescence assays confirmed the viability of GA in reducing ROS formation in solutions containing other metal ions and Aβ. Fluorescence kinetics, DPPH radical clearance and high resolution X - ray photoelectron spectroscopy results revealed the reductivity of GA. Human liver hepatocellular carcinoma (HepG2) cell viability demonstrated the biocompatibility of GA at concentrations lower than 320 μM. Cytotoxic results of human neuroblastoma (SH-SY5Y) cells verified that GA can inhibit copper-related ROS damage in neuronal cells. Our findings, combined with the advantages of marine drugs, make GA a promising candidate in reducing copper-related ROS formation associated with AD therapy.

摘要

铜相关的活性氧(ROS)形成可导致与阿尔茨海默病(AD)相关的神经病理退化,这是根据淀粉样蛋白级联假说得出的。一种络合剂,可以选择性地与铜离子络合,并从铜离子和淀粉样β(Cu-Aβ 复合物)形成的复合物中捕获铜离子,可能有助于减少 ROS 的形成。在此,我们描述了从褐藻酶解产物中获得的天然寡糖络合剂——古洛糖醛酸(GA)在减少铜相关 ROS 形成方面的应用。紫外可见吸收光谱证明了 GA 与 Cu(II) 的配位。抗坏血酸消耗和香豆素-3-羧酸荧光分析证实了 GA 在含有其他金属离子和 Aβ 的溶液中减少 ROS 形成的能力。荧光动力学、DPPH 自由基清除和高分辨率 X 射线光电子能谱结果揭示了 GA 的还原性。人肝癌细胞(HepG2)活力研究表明,GA 在低于 320 μM 的浓度下具有生物相容性。人神经母细胞瘤(SH-SY5Y)细胞的细胞毒性结果证实,GA 可以抑制神经元细胞中与铜相关的 ROS 损伤。我们的研究结果结合海洋药物的优势,使 GA 成为治疗 AD 中减少铜相关 ROS 形成的有前途的候选药物。

相似文献

1
Guluronic acid can inhibit copper(II) and amyloid - β peptide coordination and reduce copper-related reactive oxygen species formation associated with Alzheimer's disease.古洛糖醛酸能抑制铜(II)和淀粉样-β肽的配位,减少与阿尔茨海默病相关的铜相关活性氧的形成。
J Inorg Biochem. 2023 Aug;245:112252. doi: 10.1016/j.jinorgbio.2023.112252. Epub 2023 May 6.
2
Guluronic acid disaccharide inhibits reactive oxygen species production and amyloid-β oligomer formation.古洛糖醛酸二糖可抑制活性氧的产生和淀粉样β寡聚物的形成。
Biochem Biophys Res Commun. 2024 Dec 10;737:150467. doi: 10.1016/j.bbrc.2024.150467. Epub 2024 Jul 29.
3
Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.含铜(II)淀粉样β复合物和聚集体促进的抗坏血酸氧化的反应速率和机制。
J Phys Chem B. 2010 Apr 15;114(14):4896-903. doi: 10.1021/jp9095375.
4
Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.具有加速淀粉样β-Cu 纤维降解和降低毒性潜力的双功能肽在阿尔茨海默病模型大鼠中的药效学研究。
Acta Biomater. 2018 Jan;65:327-338. doi: 10.1016/j.actbio.2017.10.039. Epub 2017 Oct 27.
5
The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.阿尔茨海默病的β-淀粉样肽在一个线性双组氨酸配位环境中结合Cu(I):对β-淀粉样肽可能的神经保护机制的深入了解。
J Am Chem Soc. 2008 Dec 31;130(52):17826-35. doi: 10.1021/ja805940m.
6
A Water-Soluble Peptoid Chelator that Can Remove Cu from Amyloid-β Peptides and Stop the Formation of Reactive Oxygen Species Associated with Alzheimer's Disease.一种可溶肽螯合剂,可从淀粉样β肽中去除 Cu,并阻止与阿尔茨海默病相关的活性氧物质的形成。
Angew Chem Int Ed Engl. 2021 Nov 8;60(46):24588-24597. doi: 10.1002/anie.202109758. Epub 2021 Oct 11.
7
Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?铜(I/II)、α/β-突触核蛋白与β-淀粉样蛋白:三者间的密切关系?
Chembiochem. 2015 Nov 2;16(16):2319-28. doi: 10.1002/cbic.201500425. Epub 2015 Sep 25.
8
Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.单体形式和纤维状形式的β-淀粉样蛋白-Cu2+复合物均不能催化生成H2O2,而是淬灭羟基自由基。
Biochemistry. 2008 Nov 4;47(44):11653-64. doi: 10.1021/bi8011093. Epub 2008 Oct 11.
9
X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.X 射线吸收光谱研究人淀粉样β肽中铜(II)的配位
Inorg Chem. 2019 May 6;58(9):6294-6311. doi: 10.1021/acs.inorgchem.9b00507. Epub 2019 Apr 23.
10
The redox chemistry of the Alzheimer's disease amyloid beta peptide.阿尔茨海默病淀粉样β肽的氧化还原化学
Biochim Biophys Acta. 2007 Aug;1768(8):1976-90. doi: 10.1016/j.bbamem.2007.02.002. Epub 2007 Feb 9.

引用本文的文献

1
Copper homeostasis and neurodegenerative diseases.铜稳态与神经退行性疾病
Neural Regen Res. 2025 Nov 1;20(11):3124-3143. doi: 10.4103/NRR.NRR-D-24-00642. Epub 2024 Nov 13.
2
Recent progress of methods for cuproptosis detection.铜死亡检测方法的最新进展。
Front Mol Biosci. 2024 Sep 4;11:1460987. doi: 10.3389/fmolb.2024.1460987. eCollection 2024.